Can I Take Saw Palmetto with Finasteride?

How Finasteride Works

Finasteride is a competitive, selective inhibitor of type II 5-alpha reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). At the 1 mg daily dose approved by the FDA for androgenetic alopecia, finasteride reduces serum DHT by roughly 65 to 70% 1. At 5 mg daily for benign prostatic hyperplasia (BPH), DHT suppression reaches approximately 70 to 75% 2.

Mechanism in Hair Loss

In the scalp, DHT binds androgen receptors in hair follicles, miniaturizing them over time. The PLESS trial (N=3,040) demonstrated that finasteride 5 mg over four years produced a 26.6% reduction in prostate volume and a corresponding symptom improvement, confirming strong on-target DHT suppression 3. For hair, the key 1998 trial (N=1,553) by Kaufman et al. Showed 1 mg finasteride increased hair count by a mean of 107 hairs in a 1-inch circle vs. A loss of 50 hairs with placebo at 24 months (P<0.001) 4.

FDA Approval Status

Finasteride 1 mg (Propecia) holds FDA approval for male pattern hair loss. Finasteride 5 mg (Proscar) holds FDA approval for BPH, both as monotherapy and in combination with doxazosin per the MTOPS trial 5. Neither approval includes concomitant use of botanical 5-AR inhibitors.

How Saw Palmetto Works

Saw palmetto (Serenoa repens) is a fatty acid-rich berry extract. Its primary proposed mechanism is partial inhibition of both type I and type II 5-alpha reductase, though in vitro data suggest the inhibition is competitive and weaker than finasteride's 6. The extract also shows weak anti-androgenic and anti-inflammatory activity at the receptor level.

Clinical Evidence for BPH

The evidence base is mixed. The Cochrane review by Tacklind et al. (2012, 32 trials, N=5,666) concluded that saw palmetto produced no significant improvement in urinary flow or symptom scores compared with placebo in men with BPH 7. The STEP trial (N=225) similarly found 160 mg twice daily was no better than placebo for lower urinary tract symptoms 8.

Evidence for Hair Loss

For androgenetic alopecia, the evidence is thin. A small 2002 pilot study (N=26) by Prager et al. Reported that 38% of men taking a saw palmetto oral blend showed hair improvement vs. 24% in the placebo group, but the sample size makes the finding inconclusive 9. No large randomized controlled trial has compared saw palmetto head-to-head with finasteride for hair regrowth.

The Pharmacodynamic Interaction: Additive 5-AR Inhibition

This is a pharmacodynamic interaction, not a pharmacokinetic one. Finasteride does not meaningfully alter saw palmetto's absorption, distribution, metabolism, or excretion, and saw palmetto does not alter finasteride's. What the two agents share is a common biological target: 5-alpha reductase.

What "Additive" Means Clinically

When two agents inhibit the same enzyme, their combined effect on DHT could theoretically be additive or even synergistic. In practice, finasteride at 1 mg already suppresses type II 5-AR so substantially (roughly 65%) that the marginal contribution of saw palmetto may be negligible. No published RCT has measured combined DHT levels in men taking both agents simultaneously.

The table below summarizes the key differences and overlaps:

| Feature | Finasteride 1 mg | Saw Palmetto 320 mg/day | |---|---|---| | 5-AR isoform targeted | Type II (selective) | Type I and II (non-selective, weaker) | | DHT suppression (serum) | 65 to 70% [1] | Unstudied in strong RCTs | | FDA-approved indication | Yes (hair loss, BPH) | No | | Anticoagulant effect | None established | Mild; case reports exist [10] | | PSA effect | Halves PSA at 6 months [2] | May lower PSA; data sparse | | Interaction type | Reference compound | Pharmacodynamic (same target) |

Does Combined Use Increase Hair Regrowth?

There is no controlled evidence that adding saw palmetto to finasteride produces better hair outcomes than finasteride alone. The Kaufman et al. Trial 4 established finasteride's benefit without any botanical co-treatment. Stacking an unproven supplement on top of a proven drug is a common patient behavior, but it introduces risks without a demonstrated benefit ceiling to justify those risks.

Bleeding Risk: The More Pressing Safety Concern

Saw palmetto carries a mild anticoagulant effect that is independent of its 5-AR activity. The mechanism is thought to involve inhibition of platelet aggregation, though the pathway is not fully characterized 10.

Case Reports

Spontaneous bleeding events linked to saw palmetto include a case of intraoperative hemorrhage reported by Cheema et al. In a patient undergoing surgery who had been taking saw palmetto without disclosing it to the surgical team 11. A separate case described subdural hematoma in a 53-year-old man taking saw palmetto 450 mg daily 12. These are isolated reports, not epidemiological data, but they inform perioperative guidance.

Pre-Surgical Guidance

The Natural Medicines Database and standard perioperative supplement protocols recommend stopping saw palmetto at least two weeks before elective surgery 13. Finasteride itself does not carry an established bleeding risk.

Drug Interactions with Anticoagulants

If a patient is already taking warfarin, clopidogrel, aspirin, or a direct oral anticoagulant (DOAC) such as apixaban or rivaroxaban, adding saw palmetto may compound platelet inhibition. The American Heart Association's guidance on dietary supplements notes that botanical antiplatelet agents can potentiate pharmaceutical anticoagulants in ways that are difficult to predict from INR monitoring alone 14.

PSA Monitoring Complications

Both finasteride and saw palmetto may suppress PSA (prostate-specific antigen), though through different mechanisms. Finasteride's effect on PSA is well-characterized: the FDA label for finasteride 5 mg states that PSA is reduced by approximately 50% after 6 to 12 months of therapy, and clinicians should double the observed PSA value to approximate the true level in treated men 2.

Saw Palmetto's PSA Effect

Saw palmetto's effect on PSA is less consistent and less studied. A secondary analysis from the CAMUS trial found no significant PSA suppression with saw palmetto vs. Placebo 15. Still, some studies report modest PSA reductions, which could obscure early prostate cancer signals if a clinician is unaware of the supplement use.

Practical Guidance for PSA Screening

The American Urological Association guideline on prostate cancer early detection states: "In men taking 5-alpha reductase inhibitors, PSA should be interpreted using the adjusted (doubled) value." 16 When saw palmetto is added on top, no validated adjustment factor exists. Disclosing both agents to the ordering clinician is not optional; it directly affects the clinical interpretation of the PSA result.

Hormone Profile: What Happens to Testosterone?

Because both agents reduce DHT, circulating testosterone may rise modestly. Finasteride 1 mg raises total testosterone by approximately 15% above baseline, a finding consistent across multiple pharmacokinetic studies 17. Saw palmetto's effect on testosterone is inconsistent across trials, with some studies showing no change and others showing a small increase.

Estrogen Considerations

Testosterone that cannot be converted to DHT may instead undergo aromatization to estradiol in peripheral tissues. This is relevant for men with obesity or those who are sensitive to estrogen-related side effects. The clinical magnitude of this effect at standard finasteride doses is modest, but adding a second 5-AR inhibitor without measured DHT monitoring could theoretically compound it.

Monitoring Recommendation

Men taking finasteride for longer than six months who choose to add saw palmetto should ask their prescriber to check a serum DHT level at baseline and again at three months. Reference ranges for males: DHT 30 to 85 ng/dL is typical 18. Suppression below 10 ng/dL has been associated with sexual side effects in susceptible individuals.

Sexual Side Effects: Does the Combination Increase Risk?

Finasteride's post-marketing profile includes reports of decreased libido, erectile dysfunction, and ejaculatory dysfunction, collectively described in the FDA label and further characterized in the PFS Network literature. The PCPT trial (N=18,882) reported sexual adverse events in roughly 3 to 4% of finasteride-treated men vs. 1.5 to 2% placebo 19.

Saw Palmetto's Sexual Side Effect Profile

Saw palmetto's sexual side effect data are limited. The Cochrane review by Tacklind et al. Found that saw palmetto 320 mg/day did not produce significantly more sexual dysfunction than placebo across the 32 included trials 7. However, given that both agents target the same hormonal axis, the theoretical risk of additive sexual dysfunction from dual 5-AR inhibition cannot be ruled out.

Patient Disclosure

The FDA label for finasteride 1 mg carries a specific warning about persistent sexual side effects. Patients already experiencing side effects on finasteride alone should not add saw palmetto hoping to reduce their finasteride dose without prescriber guidance, because dose adjustments to finasteride alter the studied efficacy-safety balance.

What the Guidelines Say

No major hair loss or urology guideline currently endorses combining saw palmetto with finasteride as a standard treatment protocol. The American Hair Loss Association does not list saw palmetto as a first-line or adjuvant treatment. The AUA/SUFU guideline on BPH (2021 update) recommends finasteride or dutasteride as first-line 5-AR inhibitor therapy and does not include botanical agents as evidence-based alternatives or additions 20.

The 2021 AUA guideline states directly: "Phytotherapy is not recommended for the treatment of LUTS/BPH due to insufficient high-quality evidence supporting its use." 20 That position has not changed in the 2023 literature review update.

Practical Clinical Checklist Before Combining Both

The following steps apply whether you are taking finasteride for hair loss or BPH and are considering adding saw palmetto:

1. Tell your prescriber or telehealth clinician before starting saw palmetto.
2. Confirm you are not taking anticoagulants or antiplatelet agents. If you are, saw palmetto is likely contraindicated in addition.
3. Request a baseline PSA and DHT level so future results can be interpreted correctly.
4. Stop saw palmetto at least 14 days before any elective surgical procedure.
5. Do not reduce your finasteride dose without guidance under the assumption that saw palmetto will compensate.
6. Report any new bleeding symptoms, prolonged bruising, or changes in sexual function promptly.

When Saw Palmetto Is Sometimes Chosen Alongside Finasteride

Some men choose to add saw palmetto because they prefer a dual approach to DHT suppression, because they have read marketing claims about synergistic effects, or because they want a "natural" component in their regimen. The absence of an RCT demonstrating harm from the combination is not the same as evidence of safety or benefit.

Topical Saw Palmetto

One area where the interaction risk is lower involves topical saw palmetto formulations. When applied directly to the scalp, systemic absorption is minimal, and the risk of pharmacodynamic overlap with oral finasteride is correspondingly lower. A 2020 study by Rossi et al. (N=50) found that a topical formulation combining 2% saw palmetto oil produced results similar to 1% minoxidil in a randomized trial, though it was not compared to finasteride 21. Systemic DHT was not measured, limiting conclusions about hormonal overlap.

Men Who Are Finasteride Non-Responders

In clinical practice, a small subset of men with androgenetic alopecia show limited response to finasteride at 12 to 18 months. Some clinicians have explored adjuvant options including oral minoxidil (at 2.5 to 5 mg/day), low-level laser therapy, or platelet-rich plasma. Saw palmetto has not been studied in finasteride non-responders in a controlled setting, so its value in this scenario remains speculative.